Last checked at 3 Nov 2014 16:08
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hikma Pharmaceuticals Share News (HIK)
HIK Share
Price
HIK Share
News
HIK Share
Chat
HIK Share
Trades941
HIK
Live RNS
HIK Share
Charts
HIK Level 2
Console
HIK Live
Share Price
HIK Broker
Ratings
HIK Directors
Deals
HIK Financial
Diary
HIK
Fundamentals
HIK Short
Positions
HIK
Media
Hikma Pharmaceuticals Information
Share Price Information for Hikma Pharmaceuticals (HIK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,819.00
Bid:
1,819.00
Ask:
1,821.00
Change:
1.00 (0.06%)
Spread:
2.00 (0.11%)
Open:
1,825.00
High:
1,832.00
Low:
1,813.00
Prev. Close:
1,818.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.3 Nov 2014 06:15
31 Oct 2014 16:18
31 Oct 2014 06:19
30 Oct 2014 16:10
24 Oct 2014 11:33
London midday: UK stocks hit by Ebola worries, travel stocks fall
UK stocks fell on Friday morning after the FTSE 100 hit its highest level in two weeks the previous session, with investors treading cautiously after another reported case of Ebola in the States. The Footsie was down 0.3% at 6,397 by midday, but had pared losses after hitting a low of 6,374.24 early
Read more24 Oct 2014 11:29
24 Oct 2014 10:42
UPDATE 2-Hikma Pharma shares slip on FDA warning for Portugal plant
* Receives FDA warning letter related to environmental monitoring * Says Portugal plant was inspected in March * Sees no impact on manufacturing, distribution from plant * Says warning not to impact full-year financial guidance * Stock slips 6 pct; top loser on FTSE-250 Mi
Read more24 Oct 2014 08:35
London open: Ebola fears hit UK stocks after NY doctor tests positive for virus
UK stocks experienced some selling pressure on Friday morning after rising to their highest in two weeks, as renewed concerns about the spread of Ebola weighed on market sentiment. The FTSE 100 was down 0.6% at 6,380 in early deals, after having closed Thursday's session at 6,419.15, its highest fin
Read more24 Oct 2014 07:38
Hikma Pharmaceuticals receives warning letter from FDA
Pharmaceuticals group Hikma received a warning letter from the US Food and Drug Administration overnight relating to its manufacturing facility in Portugal. The agency raised issues related to investigations and environmental monitoring at the facility. The warning is not expected to impact the manu
Read more